Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Cyclopentolate hydrochloride

Cyclopentolate hydrochloride: 0 brands, 13 generics; first approved Feb 25, 1983; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 13 ANDA applications approved.

Brands (NDA)
0
Generics (ANDA)
13
Listed patents
0
Presentations
13

Generic (ANDA) products (13)

Abbreviated applications
  • CYCLOPENTOLATE HYDROCHLORIDE
    ANDA 2059372015
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.5%SOLUTION/DROPSOPHTHALMICDiscontinued
  • ANDA 0401641997
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICRxAT
  • ANDA 0401651997
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    2%SOLUTION/DROPSOPHTHALMICRxAT
  • ANDA 0400751994
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICRxAT
  • CYCLOPENTOLATE HYDROCHLORIDE
    ANDA 0891621991
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICDiscontinued
  • ANDA 0886431987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.5%SOLUTION/DROPSOPHTHALMICDiscontinued
  • ANDA 0881501983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICDiscontinued
  • ANDA 085555
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICDiscontinued
  • ANDA 084109
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    0.5%SOLUTION/DROPSOPHTHALMICRx
  • ANDA 084110
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICRxAT
  • ANDA 084108
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    2%SOLUTION/DROPSOPHTHALMICRxAT
  • CYCLOPENTOLATE HYDROCHLORIDE
    ANDA 084150
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICDiscontinued
  • CYCLOPENTOLATE HYDROCHLORIDE
    ANDA 084863
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    1%SOLUTION/DROPSOPHTHALMICDiscontinued

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
44 yr 2 mo ago
Most recent approval
10 yr 10 mo ago

Approvals span 1983–2015 across 13 FDA applications.

Brand (NDA) 00%
Generic (ANDA) 13100%

Cyclopentolate hydrochloride: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.